✦ LIBER ✦

Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: A Phase 1 dose-escalation study in healthy adults

✍ Scribed by Cummings, James F.; Guerrero, Melanie L.; Moon, James E.; Waterman, Paige; Nielsen, Robin K.; Jefferson, Stacie; Gross, F. Liaini; Hancock, Kathy; Katz, Jacqueline M.; Yusibov, Vidadi

Book ID: 121799973
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 858 KB
Volume: 32
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2013.10.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomised, single-blind, dose-range s

A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations

✍ Christoph Hatz; Jakob P. Cramer; André Vertruyen; Tino F. Schwarz; Frank von Son 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 376 KB

Phase I and II randomised trials of the

Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults

✍ Terry M. Nolan; Peter C. Richmond; Maryanne V. Skeljo; Georgina Pearce; Gunter H 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 591 KB

Safety and immunogenicity of a virus-lik

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers

✍ Low, Jenny G.H.; Lee, Lawrence S.; Ooi, Eng Eong; Ethirajulu, Kantharaj; Yeo, Pa 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 755 KB

Safety and immunogenicity of inactivated

Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults

✍ Wendy A. Keitel; Cornelia L. Dekker; ChrisAnna Mink; James D. Campbell; Kathryn 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 338 KB

A Phase III, randomized study to evaluat

A Phase III, randomized study to evaluate the immunogenicity and safety of an MF59®-adjuvanted A/H1N1 pandemic influenza vaccine in HIV-positive adults

✍ Diaz, Ricardo Sobhie; Tenore, Simone Barros; da Silva, Mônica M. Gomes; da Cunha 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 515 KB

Safety and immunogenicity of a trivalent

Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: A phase III open-label single-arm study

✍ M. Loebermann; G. Anders; G. Brestrich; C. Fritzsche; S. Klammt; D. Boršo; S. Fr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 267 KB